国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Lactobacillus reuteri Ribosome maturation factor RimP (rimP) CSB-YP452291LMV
CSB-EP452291LMV
CSB-BP452291LMV
CSB-MP452291LMV
CSB-EP452291LMV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri Chaperone protein DnaK (dnaK), partial CSB-YP452292LMV
CSB-EP452292LMV
CSB-BP452292LMV
CSB-MP452292LMV
CSB-EP452292LMV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri CCA-adding enzyme (cca) CSB-YP452293LMV
CSB-EP452293LMV
CSB-BP452293LMV
CSB-MP452293LMV
CSB-EP452293LMV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri Hydroxyethylthiazole kinase (thiM) CSB-YP452294LMV
CSB-EP452294LMV
CSB-BP452294LMV
CSB-MP452294LMV
CSB-EP452294LMV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri tRNA (guanine-N (7)-)-methyltransferase CSB-YP452295LMV
CSB-EP452295LMV
CSB-BP452295LMV
CSB-MP452295LMV
CSB-EP452295LMV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri Glutamyl-tRNA (Gln) amidotransferase subunit A CSB-YP452296LMV
CSB-EP452296LMV
CSB-BP452296LMV
CSB-MP452296LMV
CSB-EP452296LMV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri 50S ribosomal protein L36 (rpmJ) CSB-YP452297LMV
CSB-EP452297LMV
CSB-BP452297LMV
CSB-MP452297LMV
CSB-EP452297LMV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri 50S ribosomal protein L14 (rplN) CSB-YP452298LMV
CSB-EP452298LMV
CSB-BP452298LMV
CSB-MP452298LMV
CSB-EP452298LMV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri 30S ribosomal protein S10 (rpsJ) CSB-YP452299LMV
CSB-EP452299LMV
CSB-BP452299LMV
CSB-MP452299LMV
CSB-EP452299LMV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri Cobyrinic acid A,C-diamide synthase (cobB) CSB-YP452300LMV
CSB-EP452300LMV
CSB-BP452300LMV
CSB-MP452300LMV
CSB-EP452300LMV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus fermentum Protease HtpX homolog (htpX), partial CSB-YP452301LMO1
CSB-EP452301LMO1
CSB-BP452301LMO1
CSB-MP452301LMO1
CSB-EP452301LMO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus fermentum Cysteine--tRNA ligase (cysS) CSB-YP452302LMO
CSB-EP452302LMO
CSB-BP452302LMO
CSB-MP452302LMO
CSB-EP452302LMO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus fermentum Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP452303LMO
CSB-EP452303LMO
CSB-BP452303LMO
CSB-MP452303LMO
CSB-EP452303LMO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus fermentum Glycerol-3-phosphate dehydrogenase [NAD (P)+] CSB-YP452304LMO
CSB-EP452304LMO
CSB-BP452304LMO
CSB-MP452304LMO
CSB-EP452304LMO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus fermentum SsrA-binding protein (smpB) CSB-YP452305LMO
CSB-EP452305LMO
CSB-BP452305LMO
CSB-MP452305LMO
CSB-EP452305LMO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus fermentum Uracil phosphoribosyltransferase (upp) CSB-YP452306LMO
CSB-EP452306LMO
CSB-BP452306LMO
CSB-MP452306LMO
CSB-EP452306LMO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus fermentum 30S ribosomal protein S4 (rpsD) CSB-YP452307LMO
CSB-EP452307LMO
CSB-BP452307LMO
CSB-MP452307LMO
CSB-EP452307LMO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus fermentum Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP452308LMO
CSB-EP452308LMO
CSB-BP452308LMO
CSB-MP452308LMO
CSB-EP452308LMO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus fermentum Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial CSB-YP452309LMO
CSB-EP452309LMO
CSB-BP452309LMO
CSB-MP452309LMO
CSB-EP452309LMO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus fermentum 30S ribosomal protein S20 (rpsT) CSB-YP452310LMO
CSB-EP452310LMO
CSB-BP452310LMO
CSB-MP452310LMO
CSB-EP452310LMO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>